VivoSim Labs, INC. financial data

Symbol
VIVS on Nasdaq
Location
San Diego, CA
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 11 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 328% % 68%
Quick Ratio 9.4% %
Debt-to-equity 37% % -56%
Return On Equity -16% % 96%
Return On Assets -11% % 94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,607,962 shares -85%
Common Stock, Shares, Outstanding 2,607,962 shares -85%
Entity Public Float $7,720,472 USD 972%
Common Stock, Value, Issued $3,000 USD -82%
Weighted Average Number of Shares Outstanding, Basic 2,607,962 shares 73%
Weighted Average Number of Shares Outstanding, Diluted 2,607,962 shares 73%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $142,000 USD 16%
Research and Development Expense $3,923,000 USD -25%
Costs and Expenses $11,596,000 USD -8.5%
Operating Income (Loss) $11,454,000 USD 8.8%
Nonoperating Income (Expense) $10,229,000 USD 5745%
Income Tax Expense (Benefit) $2,000 USD 0%
Net Income (Loss) Attributable to Parent $1,227,000 USD 90%
Earnings Per Share, Basic 1.85 USD/shares 55%
Earnings Per Share, Diluted 1.85 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,288,000 USD 269%
Accounts Receivable, after Allowance for Credit Loss, Current $33,000 USD 27%
Inventory, Net $0 USD -100%
Other Assets, Current $12,000 USD 200%
Assets, Current $6,041,000 USD 188%
Property, Plant and Equipment, Net $248,000 USD -48%
Operating Lease, Right-of-Use Asset $525,000 USD -46%
Assets $6,960,000 USD 81%
Accounts Payable, Current $671,000 USD -28%
Employee-related Liabilities, Current $232,000 USD -30%
Accrued Liabilities, Current $818,000 USD -19%
Liabilities, Current $2,475,000 USD -16%
Operating Lease, Liability, Noncurrent $44,000 USD -92%
Liabilities $2,519,000 USD -28%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD 0%
Retained Earnings (Accumulated Deficit) $350,236,000 USD -0.35%
Stockholders' Equity Attributable to Parent $4,441,000 USD 1120%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,441,000 USD 1120%
Liabilities and Equity $6,960,000 USD 81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,940,000 USD -32%
Net Cash Provided by (Used in) Financing Activities $1,683,000 USD -73%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 2,607,962 shares -85%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,257,000 USD -169%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,000 USD
Deferred Tax Assets, Valuation Allowance $2,807,000 USD -5.9%
Deferred Tax Assets, Gross $3,061,000 USD -9.3%
Operating Lease, Liability $577,000 USD -46%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,691,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid $597,000 USD -47%
Property, Plant and Equipment, Gross $1,940,000 USD 0.68%
Operating Lease, Liability, Current $533,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $459,000 USD -0.22%
Lessee, Operating Lease, Liability, to be Paid, Year One $138,000 USD -74%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,000 USD -72%
Lessee, Operating Lease, Liability, to be Paid, Year Three $538,000 USD 0%
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $460,000 USD 0%
Operating Lease, Payments $538,000 USD 3.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $61,000 USD -13%
Deferred Tax Assets, Net of Valuation Allowance $254,000 USD -35%
Share-based Payment Arrangement, Expense $308,000 USD -52%